Early research (Phase 1)Study completedNCT00001577
What this trial is testing
Pilot Study of a Double Isolation Perfusion Schedule Using Melphalan Alone for Intransit Melanoma or Unresectable Sarcoma of the Extremity
Who this might be right for
MelanomaSarcoma
National Cancer Institute (NCI) 30